Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sachin A. Dhawale, Pallavi Bhosle, Sadhana Mahajan, Geetanjali Patil, Sachin Gawale, Mangesh Ghodke, Ganesh Tapadiya & Azim Ansari. (2023) Dual targeting in prostate cancer with phytoconstituents as a potent lead: a computational approach for novel drug discovery. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Read now
Shinya Fujii & Hiroyuki Kagechika. (2019) Androgen receptor modulators: a review of recent patents and reports (2012-2018). Expert Opinion on Therapeutic Patents 29:6, pages 439-453.
Read now
Read now
Shu-Pin Huang, Bo-Ying Bao, Ming-Tsang Wu, Toni K. Choueiri, William B. Goggins, Chia-Chu Liu, Chao-Yuan Huang, Yeong-Shiau Pu, Chia-Cheng Yu, Tony T. Wu, Chun-Nung Huang, Chun-Hsiung Huang & Wen-Jeng Wu. (2012) Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy. The Aging Male 15:1, pages 34-41.
Read now
Read now
Daniel R. Ciocca, Mariel A. Fanelli, Fernando D. Cuello-Carrion & Gisela N. Castro. (2010) Heat shock proteins in prostate cancer: from tumorigenesis to the clinic. International Journal of Hyperthermia 26:8, pages 737-747.
Read now
Read now
Articles from other publishers (48)
MURALIKRISHNA YARAGANI, PRASAD YADLAPALLI, SRIRAM RAGHAVAN, NIRAIKULAM AYYADURAI, SARAVANAN CHINNUSAMY, VENKATA BASAVESWARA RAO MANDAVA & RAJASEKHARA PRASAD KOTTAPALLI. (2020) Design and synthesis of novel tetrahydrofuran cyclic urea derivatives as androgen receptor antagonists. Journal of Chemical Sciences 132:1.
Crossref
Crossref
Hitomi Koga, Mai Negishi, Marie Kinoshita, Shinya Fujii, Shuichi Mori, Mari Ishigami-Yuasa, Emiko Kawachi, Hiroyuki Kagechika & Aya Tanatani. (2020) Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore. International Journal of Molecular Sciences 21:15, pages 5584.
Crossref
Crossref
Shih‐Yin Huang, Guan‐Jhong Huang, Po‐Fan Hsieh, Hsi‐Chin Wu & Wen‐Chin Huang. (2019) Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression. The Prostate 79:13, pages 1543-1552.
Crossref
Crossref
Jian Wang, Wei Yuan, Chuang Yue, Feng Dai, Shenglin Gao, Yuanyuan Mi, Yu Bai, Lifeng Zhang, Li Zuo, Xingyu Wu & Wei Zhang. (2019) RNASEL 1623A>C variant is associated with the risk of prostate cancer in African descendants. Journal of Cellular Biochemistry 120:7, pages 11955-11964.
Crossref
Crossref
Sebastien J. Hotte, Kim N. Chi, Anthony M. Joshua, Donsheng Tu, Robyn J. Macfarlane, Rirchard W. Gregg, Joseph D. Ruether, Naveen S. Basappa, Daygen Finch, Muhammad Salim, Eric W. Winquist, Vamsee Torri, Scott North, Christian Kollmannsberger, Susan L. Ellard, Bernard J. Eigl, Anna Tinker, Alison L. Allan, Kevin Beja, Matti Annala, Jean Powers, Alexander W. Wyatt & Lesley Seymour. (2019) A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205. Clinical Genitourinary Cancer 17:3, pages 201-208.e1.
Crossref
Crossref
Shih-Yin Huang, Guan-Jhong Huang, Hsi-Chin Wu, Ming-Ching Kao & Wen-Chin Huang. (2018) Ganoderma tsugae Inhibits the SREBP-1/AR Axis Leading to Suppression of Cell Growth and Activation of Apoptosis in Prostate Cancer Cells. Molecules 23:10, pages 2539.
Crossref
Crossref
Yuko Kazui, Shinya Fujii, Ayumi Yamada, Mari Ishigami-Yuasa, Hiroyuki Kagechika & Aya Tanatani. (2018) Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents. Bioorganic & Medicinal Chemistry 26:18, pages 5118-5127.
Crossref
Crossref
Hirozumi Toyama, Hitoshi Shirakawa, Michio Komai, Yuichi Hashimoto & Shinya Fujii. (2018) Development of novel silanol-based human pregnane X receptor (PXR) agonists with improved receptor selectivity. Bioorganic & Medicinal Chemistry 26:15, pages 4493-4501.
Crossref
Crossref
Blake T. Riley, Olga Ilyichova, Jonathan M. Harris, David E. Hoke & Ashley M. Buckle. 2018. Extracellular Targeting of Cell Signaling in Cancer. Extracellular Targeting of Cell Signaling in Cancer
277
306
.
Asako Kaise, Kiminori Ohta, Shinya Fujii, Akifumi Oda, Tokuhito Goto & Yasuyuki Endo. (2018) Novel androgen receptor full antagonists: Design, synthesis, and a docking study of glycerol and aminoglycerol derivatives that contain p-carborane cages. Bioorganic & Medicinal Chemistry 26:13, pages 3805-3811.
Crossref
Crossref
Bayala Balé, Halabalaki Maria, Ouedraogo Amad&eacut, Keiler Martina Annekathri, Tamboura Hamidou Ha & Vollmer Günte. (2018) Leptadenia hastata Pers. (Decne) a Promising Source for Natural
Compounds in Biomedical Applications. American Journal of Drug Discovery and Development 8:1, pages 1-10.
Crossref
Crossref
Xuehai Pang, Lingling Peng & Yuanwei Chen. (2017)
Effect of
N
-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide
. Journal of Labelled Compounds and Radiopharmaceuticals 60:9, pages 401-409.
Crossref
Crossref
Chao Zhao, You Hee Choi, Daulat Bikram Khadka, Yifeng Jin, Kwang-Youl Lee & Won-Jea Cho. (2016) Design and synthesis of novel androgen receptor antagonists via molecular modeling. Bioorganic & Medicinal Chemistry 24:4, pages 789-801.
Crossref
Crossref
Emma K. Beardsley, Mark Frydenberg & Gail P. Risbridger. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
2467
2484.e5
.
Kazumi Inoue, Ko Urushibara, Misae Kanai, Kei Yura, Shinya Fujii, Mari Ishigami-Yuasa, Yuichi Hashimoto, Shuichi Mori, Emiko Kawachi, Mio Matsumura, Tomoya Hirano, Hiroyuki Kagechika & Aya Tanatani. (2015) Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists. European Journal of Medicinal Chemistry 102, pages 310-319.
Crossref
Crossref
Khaled Lotfy. (2015) Molecular Modeling, Docking and ADMET of Dimethylthiohydantoin Derivatives for Prostate Cancer Treatment. Journal of Biophysical Chemistry 06:04, pages 91-117.
Crossref
Crossref
P-C Kuo, C-W Huang, C-I Lee, H-W Chang, S-W Hsieh, Y-P Chung, M-S Lee, C-S Huang, L-P Tsao, Y-P Tsao & S-L Chen. (2014) BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability. British Journal of Cancer 112:2, pages 391-402.
Crossref
Crossref
C. M. Nieto, L. C. Rider & S. D. Cramer. (2014) Influence of stromal-epithelial interactions on androgen action. Endocrine Related Cancer 21:4, pages T147-T160.
Crossref
Crossref
Weiguo Liu, Jinming Zhou, Guoyan Geng, Rongtuan Lin & Jian Hui Wu. (2013) Synthesis and in vitro characterization of ionone-based compounds as dual inhibitors of the androgen receptor and NF-κB. Investigational New Drugs 32:2, pages 227-234.
Crossref
Crossref
Ayumi Yamada, Shinya Fujii, Shuichi Mori & Hiroyuki Kagechika. (2013) Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists. ACS Medicinal Chemistry Letters 4:10, pages 937-941.
Crossref
Crossref
Shuping Li, Miaofen G. Hu, Yeqing Sun, Norie Yoshioka, Soichiro Ibaragi, Jinghao Sheng, Guangjie Sun, Koji Kishimoto & Guo-Fu Hu. (2013) Angiogenin Mediates Androgen-Stimulated Prostate Cancer Growth and Enables Castration Resistance. Molecular Cancer Research 11:10, pages 1203-1214.
Crossref
Crossref
Xiangyan Li, Yi-Ting Chen, Sajni Josson, Nishit K. Mukhopadhyay, Jayoung Kim, Michael R. Freeman & Wen-Chin Huang. (2013) MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells. PLoS ONE 8:8, pages e70987.
Crossref
Crossref
Natalie Sampson, Christoph Zenzmaier, Martin Heitz, Martin Hermann, Eugen Plas, Georg Schäfer, Helmut Klocker & Peter Berger. (2013) Stromal Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) Is Elevated in the Diseased Human Prostate and Promotes ex Vivo Fibroblast-to-Myofibroblast Differentiation. Endocrinology 154:8, pages 2586-2599.
Crossref
Crossref
Robert H. Bradbury, David G. Acton, Nicola L. Broadbent, A. Nigel Brooks, Gregory R. Carr, Glenn Hatter, Barry R. Hayter, Kathryn J. Hill, Nicholas J. Howe, Rhys D.O. Jones, David Jude, Scott G. Lamont, Sarah A. Loddick, Heather L. McFarland, Zaieda Parveen, Alfred A. Rabow, Gorkhn Sharma-Singh, Natalie C. Stratton, Andrew G. Thomason, Dawn Trueman, Graeme E. Walker, Stuart L. Wells, Joanne Wilson & J. Matthew Wood. (2013) Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer. Bioorganic & Medicinal Chemistry Letters 23:7, pages 1945-1948.
Crossref
Crossref
Stefania Staibano. 2013. Prostate Cancer: Shifting from Morphology to Biology. Prostate Cancer: Shifting from Morphology to Biology
127
142
.
Bing Liu, Guoyan Geng, Rongtuan Lin, Cuiyan Ren & Jian Hui Wu. (2012) Learning From Estrogen Receptor Antagonism: Structure-Based Identification of Novel Antiandrogens Effective Against Multiple Clinically Relevant Androgen Receptor Mutants. Chemical Biology & Drug Design 79:3, pages 300-312.
Crossref
Crossref
Weiguo Liu, Jinming Zhou, Guoyan Geng, Qingwen Shi, Francoise Sauriol & Jian Hui Wu. (2012) Antiandrogenic, Maspin Induction, and Antiprostate Cancer Activities of Tanshinone IIA and Its Novel Derivatives with Modification in Ring A. Journal of Medicinal Chemistry 55:2, pages 971-975.
Crossref
Crossref
Shinya Fujii, Kiminori Ohta, Tokuhito Goto, Akifumi Oda, Hiroyuki Masuno, Yasuyuki Endo & Hiroyuki Kagechika. (2012) Development of androgen receptor ligands by application of ten-vertex para-carborane as a novel hydrophobic core structure. MedChemComm 3:6, pages 680.
Crossref
Crossref
Michael Frezza, Huanjie Yang & Q. Ping Dou. (2011) Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli. Journal of Cellular Physiology 226:11, pages 2731-2739.
Crossref
Crossref
Robert H. Bradbury, Neil J. Hales, Alfred A. Rabow, Graeme E. Walker, David G. Acton, David M. Andrews, Peter Ballard, Nigel A.N. Brooks, Nicola Colclough, Alan Girdwood, Urs J. Hancox, Owen Jones, David Jude, Sarah A. Loddick & Andrew A. Mortlock. (2011) Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer. Bioorganic & Medicinal Chemistry Letters 21:18, pages 5442-5445.
Crossref
Crossref
Bertrand Tombal. (2011) What is the pathophysiology of a hormone-resistant prostate tumour?. European Journal of Cancer 47, pages S179-S188.
Crossref
Crossref
Shu-Pin Huang, Bo-Ying Bao, Ming-Tsang Wu, Toni K. Choueiri, William B. Goggins, Chao-Yuan Huang, Yeong-Shiau Pu, Chia-Cheng Yu & Chun-Hsiung Huang. (2011) Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy. The Prostate 71:11, pages 1189-1197.
Crossref
Crossref
Kiminori Ohta, Tokuhito Goto, Shinya Fujii, Masatoshi Kawahata, Akifumi Oda, Shigeru Ohta, Kentaro Yamaguchi, Shuichi Hirono & Yasuyuki Endo. (2011) Crystal structure, docking study and structure–activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile. Bioorganic & Medicinal Chemistry 19:11, pages 3540-3548.
Crossref
Crossref
Natalie SampsonRafal KozielChristoph ZenzmaierLukas BubendorfEugen Plas, Pidder Jansen-DürrPeter Berger. (2011) ROS Signaling by NOX4 Drives Fibroblast-to-Myofibroblast Differentiation in the Diseased Prostatic Stroma. Molecular Endocrinology 25:3, pages 503-515.
Crossref
Crossref
Costantine Albany, Ajjai S. Alva, Ana M. Aparicio, Rakesh Singal, Sarvari Yellapragada, Guru Sonpavde & Noah M. Hahn. (2011) Epigenetics in Prostate Cancer. Prostate Cancer 2011, pages 1-12.
Crossref
Crossref
Shinya Fujii, Ayumi Yamada, Keiko Tomita, Mao Nagano, Tokuhito Goto, Kiminori Ohta, Takashi Harayama, Yasuyuki Endo & Hiroyuki Kagechika. (2011) p-Carborane-based androgen antagonists active in LNCaP cells with a mutated androgen receptor. MedChemComm 2:9, pages 877.
Crossref
Crossref
Tokuhito Goto, Kiminori Ohta, Shinya Fujii, Shigeru Ohta & Yasuyuki Endo. (2010)
Design and Synthesis of Androgen Receptor Full Antagonists Bearing a
p
-Carborane Cage: Promising Ligands for Anti-Androgen Withdrawal Syndrome
. Journal of Medicinal Chemistry 53:13, pages 4917-4926.
Crossref
Crossref
Jinming Zhou, Guoyan Geng & Jian Hui Wu. (2009) Synthesis and in vitro characterization of ionone-based chalcones as novel antiandrogens effective against multiple clinically relevant androgen receptor mutants. Investigational New Drugs 28:3, pages 291-298.
Crossref
Crossref
Mari Nakabayashi, William K. Oh, Susanna Jacobus, Meredith M. Regan, Mary-Ellen Taplin, Philip W. Kantoff & Jonathan E. Rosenberg. (2009) Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer. BJU International 105:10, pages 1392-1396.
Crossref
Crossref
Wen-Chin Huang, Haiyen E. Zhau & Leland W. K. Chung. (2010) Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells. Journal of Biological Chemistry 285:11, pages 7947-7956.
Crossref
Crossref
Wenhui Zhu, David S Zhu, Ravi A Madan, James L Gulley, William D Figg & William L Dahut. (2010) Treatment of Castration-Resistant Prostate Cancer: Updates on Therapeutics Targeting the Androgen Receptor Signaling Pathway. American Journal of Therapeutics 17:2, pages 176-181.
Crossref
Crossref
Gail P. Risbridger, Simon W. Hayward, Peter E. Clark, Mark Frydenberg & Sree Appu. 2010. Endocrinology. Endocrinology
2592
2609
.
Jian Hui Wu. 2010. Alternative and Complementary Therapies for Cancer. Alternative and Complementary Therapies for Cancer
671
692
.
Jinming Zhou, Guoyan Geng, Qingwen Shi, Francoise Sauriol & Jian Hui Wu. (2009) Design and Synthesis of Androgen Receptor Antagonists with Bulky Side Chains for Overcoming Antiandrogen Resistance. Journal of Medicinal Chemistry 52:17, pages 5546-5550.
Crossref
Crossref
Debashis Sarker, Alison H.M. Reid, Timothy A. Yap & Johann S. de Bono. (2009) Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer. Clinical Cancer Research 15:15, pages 4799-4805.
Crossref
Crossref
Jennifer A. Locke, Colleen C. Nelson, Hans H. Adomat, Stephen C. Hendy, Martin E. Gleave & Emma S. Tomlinson Guns. (2009) Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts. The Journal of Steroid Biochemistry and Molecular Biology 115:3-5, pages 126-136.
Crossref
Crossref
Catherine Itman, Chris Small, Michael Griswold, Ankur K. Nagaraja, Martin M. Matzuk, Chester W. Brown, David A. Jans & Kate L. Loveland. (2009) Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes. Developmental Dynamics 238:7, pages 1688-1700.
Crossref
Crossref
Begoña Mellado, Jordi Codony, María José Ribal, Laura Visa & Pere Gascón. (2009) Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway. Clinical and Translational Oncology 11:1, pages 5-10.
Crossref
Crossref